Cargando…

Structure-based development and preclinical evaluation of the SARS-CoV-2 3C-like protease inhibitor simnotrelvir

The persistent pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variants accentuates the great demand for developing effective therapeutic agents. Here, we report the development of an orally bioavailable SARS-CoV-2 3C-lik...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Xiangrui, Su, Haixia, Shang, Weijuan, Zhou, Feng, Zhang, Yan, Zhao, Wenfeng, Zhang, Qiumeng, Xie, Hang, Jiang, Lei, Nie, Tianqing, Yang, Feipu, Xiong, Muya, Huang, Xiaoxing, Li, Minjun, Chen, Ping, Peng, Shaoping, Xiao, Gengfu, Jiang, Hualiang, Tang, Renhong, Zhang, Leike, Shen, Jingshan, Xu, Yechun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10575921/ https://www.ncbi.nlm.nih.gov/pubmed/37833261 http://dx.doi.org/10.1038/s41467-023-42102-y

Ejemplares similares

Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease
por: Su, Haixia, et al.
Publicado: (2021)

Design, synthesis and biological evaluation of covalent peptidomimetic 3CL protease inhibitors containing nitrile moiety
por: Zhu, Mengwei, et al.
Publicado: (2023)

In silico screening-based discovery of novel covalent inhibitors of the SARS-CoV-2 3CL protease
por: Xiong, Muya, et al.
Publicado: (2022)

A viral RNA-dependent RNA polymerase inhibitor VV116 broadly inhibits human coronaviruses and has synergistic potency with 3CLpro inhibitor nirmatrelvir
por: Zhang, Yumin, et al.
Publicado: (2023)

Design, synthesis and biological evaluation of peptidomimetic benzothiazolyl ketones as 3CL(pro) inhibitors against SARS-CoV-2
por: Yang, Hanxi, et al.
Publicado: (2023)

In vitro and in vivo evaluation of the main protease inhibitor FB2001 against SARS-CoV-2
por: Shang, Weijuan, et al.
Publicado: (2022)

Oral remdesivir derivative VV116 is a potent inhibitor of respiratory syncytial virus with efficacy in mouse model
por: Zhang, Ruxue, et al.
Publicado: (2022)

Design and development of an oral remdesivir derivative VV116 against SARS-CoV-2
por: Xie, Yuanchao, et al.
Publicado: (2021)

Structure-Based Design of Potent Peptidomimetic Inhibitors Covalently Targeting SARS-CoV-2 Papain-like Protease
por: Wang, Qian, et al.
Publicado: (2023)

Drug discovery and development targeting the life cycle of SARS-CoV-2
por: Su, Haixia, et al.
Publicado: (2021)

Efficacy and safety of SIM0417 (SSD8432) plus ritonavir for COVID-19 treatment: a randomised, double-blind, placebo-controlled, phase 1b trial
por: Wang, Fuxiang, et al.
Publicado: (2023)

Unraveling the catalytic mechanism of SARS-CoV-2 papain-like protease with allosteric modulation of C270 mutation using multiscale computational approaches
por: Shao, Qiang, et al.
Publicado: (2023)

Comprehensive interactome analysis of the spike protein of swine acute diarrhea syndrome coronavirus
por: Wang, Qingxing, et al.
Publicado: (2021)

Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
por: Dai, Wenhao, et al.
Publicado: (2020)

Synthesis, cytotoxicity, and pharmacokinetic evaluations of niclosamide analogs for anti-SARS-CoV-2
por: Li, Rui, et al.
Publicado: (2023)

Discovery, synthesis and mechanism study of 2,3,5-substituted [1,2,4]-thiadiazoles as covalent inhibitors targeting 3C-Like protease of SARS-CoV-2
por: Ren, Pengxuan, et al.
Publicado: (2023)

High-throughput screening of SARS-CoV-2 main and papain-like protease inhibitors
por: Zang, Yi, et al.
Publicado: (2022)

Potential treatment of COVID-19 by inhibitors of human dihydroorotate dehydrogenase
por: Xu, Yechun, et al.
Publicado: (2020)

Correction: Discovery of novel non-peptidic and non-covalent small-molecule 3CL(pro) inhibitors as potential candidate for COVID-19 treatment
por: Jiang, Zhidong, et al.
Publicado: (2023)

Discovery of novel non-peptidic and non-covalent small-molecule 3CL(pro) inhibitors as potential candidate for COVID-19 treatment
por: Jiang, Zhidong, et al.
Publicado: (2023)

Comparative Antiviral Efficacy of Viral Protease Inhibitors against the Novel SARS-CoV-2 In Vitro
por: Zhang, Leike, et al.
Publicado: (2020)

Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir
por: Yin, Wanchao, et al.
Publicado: (2020)

SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target
por: Xia, Bingqing, et al.
Publicado: (2021)

Development of horse neutralizing immunoglobulin and immunoglobulin fragments against Junín virus
por: Pan, Xiaoyan, et al.
Publicado: (2020)

Computational Studies on Acetylcholinesterases
por: Xu, Yechun, et al.
Publicado: (2017)

Visualizing lymphocytic choriomeningitis virus infection in cells and living mice
por: Wen, Yuxi, et al.
Publicado: (2022)

Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives
por: Amporndanai, Kangsa, et al.
Publicado: (2021)

Mechanics of Channel Gating of the Nicotinic Acetylcholine Receptor
por: Liu, Xinli, et al.
Publicado: (2008)

Screening of FDA-Approved Drugs for Inhibitors of Japanese Encephalitis Virus Infection
por: Wang, Shaobo, et al.
Publicado: (2017)

Allosteric Regulation of Hsp90α’s Activity by Small Molecules Targeting the Middle Domain of the Chaperone
por: Zhou, Chen, et al.
Publicado: (2020)

Identification of distinct clinical phenotypes of cardiogenic shock using machine learning consensus clustering approach
por: Wang, Li, et al.
Publicado: (2023)

A Comparative Quantitative Proteomic Analysis of HCMV-Infected Cells Highlights pUL138 as a Multifunctional Protein
por: Li, Yang, et al.
Publicado: (2020)

Understanding Voltage Gating of Providencia stuartii Porins at Atomic Level
por: Song, Wanling, et al.
Publicado: (2015)

Applying high-performance computing in drug discovery and molecular simulation
por: Liu, Tingting, et al.
Publicado: (2016)

Activation of the STAT3 Signaling Pathway by the RNA-Dependent RNA Polymerase Protein of Arenavirus
por: Wang, Qingxing, et al.
Publicado: (2021)

Bispecific prodrug nanoparticles circumventing multiple immune resistance mechanisms for promoting cancer immunotherapy
por: Ye, Jiayi, et al.
Publicado: (2022)

Application of ITC-Based Characterization of Thermodynamic and Kinetic Association of Ligands With Proteins in Drug Design
por: Su, Haixia, et al.
Publicado: (2018)

Comprehensive Interactome Analysis Reveals that STT3B Is Required for N-Glycosylation of Lassa Virus Glycoprotein
por: Zhu, Shenglin, et al.
Publicado: (2019)

Two adjacent mutations on the dimer interface of SARS coronavirus 3C-like protease cause different conformational changes in crystal structure()
por: Hu, Tiancen, et al.
Publicado: (2009)

Structure basis for allosteric regulation of lymphocytic choriomeningitis virus polymerase function by Z matrix protein
por: Liu, Lu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e280eql2ucov40vph22v39jqa0